Shuho Tanaka

Shuho Tanaka

Auto-generated profile, based on publicly available information

Shuho Tanaka

University of Tsukuba

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in World Neurosurgery
Verified
Journal Article
Closed access
THTakuma Hara
Takuma Hara
HAHiroyoshi Akutsu
Hiroyoshi Akutsu
TYTetsuya Yamamoto
Tetsuya Yamamoto
STShuho Tanaka
Shuho Tanaka
STShingo Takano
Shingo Takano
AMAkira Matsumura
Akira Matsumura


17 May 2021 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
YMYusuke Morinaga
Yusuke Morinaga
HAHiroyoshi Akutsu
Hiroyoshi Akutsu
HKHiroyoshi Kino
Hiroyoshi Kino
STShuho Tanaka
Shuho Tanaka
HMHidetaka Miyamoto
Hidetaka Miyamoto
EIEiichi Ishikawa
Eiichi Ishikawa
BACKGROUND: The authors reported on the use of endoscopic endonasal surgery (EES) for clivus osteochondroma in a patient with hereditary multiple exostoses (HME), a rare pediatric disorder characterized by the formation of osteochondromas adjacent to the growth plates of the axial and appendicular skeletal elements. OBSERVATIONS: A 26-year-old man with a family history of HME reported progressive hoarseness and dysphagia over the previous 6 months. He was referred to us after magnetic resonance imaging (MRI) showed a bone tumor in the lower clivus. MRI revealed tumor proliferation in the lower clivus and its extension to the bilateral occipital condyle and jugular tubercle. The hypoglossal canal and jugular foramen were encased on the right side, whereas the medulla oblongata was compressed. The tumor was subtotally resected with EES, and the brainstem was successfully decompressed. The pathological diagnosis was exostoses. Transient postoperative worsening of dysphagia improved within 1 month without other neurological deficits. The patient underwent posterior occipitoaxial fixation 3 months after EES to correct instability and local lateral tilt of the right atlanto-occipital joint. LESSONS: The authors’ experience showed that EES is effective for resection of lower clivus osteochondromas, including the cartilaginous cap, and may improve clinical outcomes in patients with HME.

3 March 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
ATAtsushi Tsukada
Atsushi Tsukada
HKHiroyoshi Kino
Hiroyoshi Kino
AYAkinari Yamano
Akinari Yamano
STShuho Tanaka
Shuho Tanaka
MSMakoto Shibuya
Makoto Shibuya
EIEiichi Ishikawa
Eiichi Ishikawa
BACKGROUND: Ectopic pituitary neuroendocrine tumors (Pit-NETs) are rare. The authors present two cases of ectopic Pit-NETs located entirely in the suprasellar space without continuity with the normal pituitary gland. OBSERVATIONS: In case 1, a 53-year-old male presented with right blindness and left visual field impairment. Preoperative imaging suggested an ectopic Pit-NET with pituitary apoplexy. Intraoperatively, it was found to originate from the pars tuberalis of the pituitary stalk. A portion of the tumor inside the pituitary stalk was left intact, resulting in subtotal resection. Postoperatively, the patient developed diabetes insipidus (DI), but his left visual function improved. In case 2, a suprasellar tumor was incidentally discovered in a 63-year-old female who presented with a headache. Imaging revealed a tumor with a cystic component, leading to an initial diagnosis of craniopharyngioma. Intraoperatively, the tumor was found to originate from the pituitary stalk. The stalk was divided longitudinally, and total resection was achieved. Pathological diagnosis confirmed Pit-NET. The patient developed transient DI and transient worsening of visual field disturbance, both of which improved within 3 months postoperatively. LESSONS: Ectopic Pit-NETs can occasionally present with apoplexy, and preoperative differential diagnosis can be difficult based on imaging study alone. Intraoperative histopathological diagnosis could help prevent unnecessary endocrinological deficits. https://thejns.org/doi/10.3171/CASE24779

7 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HNHazuki Nitta
Hazuki Nitta
TSTakashi Saito
Takashi Saito
RMRyota Matsuoka
Ryota Matsuoka
SMShin Matsumoto
Shin Matsumoto
STShuho Tanaka
Shuho Tanaka
HSHideyuki Sakurai
Hideyuki Sakurai
Background: Sinonasal neuroendocrine carcinoma (SNEC) is an extremely rare malignancy, and, to date, no clinical reports have detailed the use of proton beam therapy (PBT) for this disease. The present study describes the clinical courses of patients with SNEC treated with PBT and highlights the advantages of PBT. Methods: In this retrospective study, we included patients with pathologically confirmed SNEC without distant metastasis who underwent PBT at our institution between 2006 and 2021. To evaluate the dosimetric advantages of PBT, comparative treatment plans using VMAT were created. Result: Six patients with pathologically diagnosed SNEC without distant metastasis were treated with PBT. Multimodal treatment was applied in five patients, including chemotherapy in four cases and surgery in two cases. The median follow-up period was 37.4 months (range: 6.9 to 108.9 months). At the end of the follow-up, three patients were alive without recurrence, while three had died due to the disease. Recurrence occurred in three cases: one local recurrence, one in cervical lymph nodes, and two distant metastases. A late adverse event of Grade 4 vision decrease was observed in one patient on the ipsilateral side. Compared with VMAT, PBT lowered the average brain dose (median 3.3 Gy (RBE) vs. 12.6 Gy), brainstem D2 cc (10.7 Gy (RBE) vs. 34.9 Gy) and contralateral optic nerve D0.1 cc (47.6 Gy (RBE) vs. 63.3 Gy), while doses to the ipsilateral optic pathway were comparable. Conclusions: PBT in multimodal treatment achieved feasible local control for SNEC. The dose-sparing effect of PBT was more evident in organs distant from the target, although careful consideration is required for adjacent structures.

25 June 2026 in Therapeutic Advances in Allergy and Rhinology
Verified
Journal Article
Closed access
MKMasayoshi Kobayashi
Masayoshi Kobayashi
THToyoyuki Hanazawa
Toyoyuki Hanazawa
TNTakayuki Nakagawa
Takayuki Nakagawa
NONobuyoshi Otori
Nobuyoshi Otori
Yasushi FujimotoYasushi Fujimoto
Yasushi Fujimoto
TATakahiro Asakage
Takahiro Asakage
Background: Endoscopic endonasal approach (EEA) has gained widespread acceptance as a surgical approach for treating sinonasal malignancies in the last decade. Objectives: This study examined the validity of the EEA as a standard modality for the surgical treatment of sinonasal malignancies. Design: A retrospective multicenter cohort study Methods: This study included patients with nasoethmoidal malignancies who underwent initial surgical treatment between 2014 and 2016 at 10 tertiary referral hospitals in Japan. The EEA, craniofacial approach (CA), and EEA combined with CA (EEAwCA) were used as the surgical methods. Results: The total number of participants was 110, with a median posttreatment observation period of 69 months. The olfactory cleft (26%) was the most frequent lesion site. Squamous cell carcinoma (29%) and olfactory neuroblastoma (24%) were the most frequently observed pathological classifications. EEA was performed in early-stage cases, and EEAwCA, which is frequently used for tumors that extend into the orbit and/or intracranial regions, was performed in advanced-stage cases. Negative-margin resection was achieved in 85%, 78%, and 64% of EEA, EEAwCA, and CA cases, respectively; postoperative radiotherapy was performed in 50%, 56%, and 36% of patients with EEA, EEAwCA, and CA, respectively; and the 5-year local control rates were 90%, 78%, and 82% for EEA, EEAwCA, and CA, respectively. En bloc resection for EEA, and postoperative irradiation for EEA and EEAwCA were associated with fewer local recurrences. Validation of the operation time, hospitalization period, intraoperative blood loss, and postoperative complications demonstrated the low invasiveness of the EEA. Conclusion: The EEA is a minimally invasive surgical modality with preferable oncological outcomes for the treatment of nasoethmoidal malignancies when adequately planned. Plain Language Summary: A look back at nose cancer surgery using a less invasive method through the nose Purpose: This study looked at a newer, less invasive surgery called the endoscopic endonasal approach (EEA), which goes through the nose to remove tumors in the nose and nearby areas. The goal was to see if this method could be used as a standard treatment. How the Study Was Done: Researchers looked back at 110 patients in Japan who had surgery for cancer in the nose and surrounding areas between 2014 and 2016. They had surgery using one of three methods: EEA (through the nose) CA (a more traditional open surgery) EEA combined with CA (used for more serious cases) What They Found: 1) Most patients had tumors in a part of the nose related to the sense of smell. 2) The most common types of cancer were squamous cell carcinoma and a rare nerve-related tumor. 3) The EEA was mostly used for early-stage cancers, and the combined method was used for more advanced cases. 4) The cancer was completely removed in about 85% of EEA cases, 78% of combined cases, and 64% of traditional cases. 5) People who had EEA had fewer side effects, lost less blood, and stayed in the hospital for a shorter time. 6) After 5 years, the cancer had not come back in 90% of EEA cases, 78% of combined cases, and 82% of traditional cases. 7) Patients who had radiation after surgery or had tumors removed in one piece had better results. Conclusion: The EEA is a safe and effective option for treating certain nose cancers, especially when it's carefully planned. It causes less harm to the body and works well for early-stage cancers.